Literature DB >> 23143785

Therapeutic roles of curcumin: lessons learned from clinical trials.

Subash C Gupta1, Sridevi Patchva, Bharat B Aggarwal.   

Abstract

Extensive research over the past half century has shown that curcumin (diferuloylmethane), a component of the golden spice turmeric (Curcuma longa), can modulate multiple cell signaling pathways. Extensive clinical trials over the past quarter century have addressed the pharmacokinetics, safety, and efficacy of this nutraceutical against numerous diseases in humans. Some promising effects have been observed in patients with various pro-inflammatory diseases including cancer, cardiovascular disease, arthritis, uveitis, ulcerative proctitis, Crohn's disease, ulcerative colitis, irritable bowel disease, tropical pancreatitis, peptic ulcer, gastric ulcer, idiopathic orbital inflammatory pseudotumor, oral lichen planus, gastric inflammation, vitiligo, psoriasis, acute coronary syndrome, atherosclerosis, diabetes, diabetic nephropathy, diabetic microangiopathy, lupus nephritis, renal conditions, acquired immunodeficiency syndrome, β-thalassemia, biliary dyskinesia, Dejerine-Sottas disease, cholecystitis, and chronic bacterial prostatitis. Curcumin has also shown protection against hepatic conditions, chronic arsenic exposure, and alcohol intoxication. Dose-escalating studies have indicated the safety of curcumin at doses as high as 12 g/day over 3 months. Curcumin's pleiotropic activities emanate from its ability to modulate numerous signaling molecules such as pro-inflammatory cytokines, apoptotic proteins, NF-κB, cyclooxygenase-2, 5-LOX, STAT3, C-reactive protein, prostaglandin E(2), prostate-specific antigen, adhesion molecules, phosphorylase kinase, transforming growth factor-β, triglyceride, ET-1, creatinine, HO-1, AST, and ALT in human participants. In clinical trials, curcumin has been used either alone or in combination with other agents. Various formulations of curcumin, including nanoparticles, liposomal encapsulation, emulsions, capsules, tablets, and powder, have been examined. In this review, we discuss in detail the various human diseases in which the effect of curcumin has been investigated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23143785      PMCID: PMC3535097          DOI: 10.1208/s12248-012-9432-8

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  99 in total

Review 1.  Update on oral lichen planus: etiopathogenesis and management.

Authors:  C Scully; M Beyli; M C Ferreiro; G Ficarra; Y Gill; M Griffiths; P Holmstrup; S Mutlu; S Porter; D Wray
Journal:  Crit Rev Oral Biol Med       Date:  1998

2.  Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients.

Authors:  Gianni Belcaro; Maria Rosaria Cesarone; Mark Dugall; Luciano Pellegrini; Andrea Ledda; Maria Giovanna Grossi; Stefano Togni; Giovanni Appendino
Journal:  Altern Med Rev       Date:  2010-12

3.  Efficacy of curcumin in the management of chronic anterior uveitis.

Authors:  B Lal; A K Kapoor; O P Asthana; P K Agrawal; R Prasad; P Kumar; R C Srimal
Journal:  Phytother Res       Date:  1999-06       Impact factor: 5.878

4.  Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.

Authors:  Pravit Asawanonda; Siri-On Klahan
Journal:  Photomed Laser Surg       Date:  2010-10       Impact factor: 2.796

5.  Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters.

Authors:  M C Heng; M K Song; J Harker; M K Heng
Journal:  Br J Dermatol       Date:  2000-11       Impact factor: 9.302

6.  Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis.

Authors:  J Curtis Nickel; Jim Xiang
Journal:  J Urol       Date:  2008-03-04       Impact factor: 7.450

7.  Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.

Authors:  Tommaso Cai; Sandra Mazzoli; Adriano Bechi; Patrizia Addonisio; Nicola Mondaini; Roberto Castricchi Pagliai; Riccardo Bartoletti
Journal:  Int J Antimicrob Agents       Date:  2009-01-31       Impact factor: 5.283

8.  Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase.

Authors:  S Reddy; B B Aggarwal
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

9.  Effect of oral curcumin on Déjérine-Sottas disease.

Authors:  Joshua Burns; Pathma D Joseph; Kristy J Rose; Monique M Ryan; Robert A Ouvrier
Journal:  Pediatr Neurol       Date:  2009-10       Impact factor: 3.372

10.  Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation.

Authors:  John Cuomo; Giovanni Appendino; Adam S Dern; Erik Schneider; Toni P McKinnon; Mark J Brown; Stefano Togni; Brian M Dixon
Journal:  J Nat Prod       Date:  2011-03-17       Impact factor: 4.050

View more
  381 in total

1.  Spinal glial activation and oxidative stress are alleviated by treatment with curcumin or coenzyme Q in sickle mice.

Authors:  Yessenia Valverde; Barbara Benson; Mihir Gupta; Kalpna Gupta
Journal:  Haematologica       Date:  2015-11-06       Impact factor: 9.941

Review 2.  Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?

Authors:  David Brown
Journal:  Nat Rev Drug Discov       Date:  2015-10-23       Impact factor: 84.694

3.  Synthesis of novel 4-Boc-piperidone chalcones and evaluation of their cytotoxic activity against highly-metastatic cancer cells.

Authors:  Carlimar Ocasio-Malavé; Metsiel J Donate; María M Sánchez; Jesús M Sosa-Rivera; Joseph W Mooney; Tomás A Pereles-De León; Néstor M Carballeira; Beatriz Zayas; Christian E Vélez-Gerena; Magaly Martínez-Ferrer; David J Sanabria-Ríos
Journal:  Bioorg Med Chem Lett       Date:  2019-10-28       Impact factor: 2.823

4.  Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.

Authors:  Bo Xiao; Xiaoying Si; Mingzhen Zhang; Didier Merlin
Journal:  Colloids Surf B Biointerfaces       Date:  2015-08-01       Impact factor: 5.268

5.  Multiple effects of curcumin on promoting expression of the exon 7-containing SMN2 transcript.

Authors:  Dairong Feng; Yi Cheng; Yan Meng; Liping Zou; Shangzhi Huang; Jiuyong Xie
Journal:  Genes Nutr       Date:  2015-09-19       Impact factor: 5.523

6.  Bridging cross-cultural gaps: monitoring herbal use during chemotherapy in patients referred to integrative medicine consultation in Israel.

Authors:  Limor Almog; Efraim Lev; Elad Schiff; Shai Linn; Eran Ben-Arye
Journal:  Support Care Cancer       Date:  2014-05-10       Impact factor: 3.603

Review 7.  Obesity-Associated Inflammation: Does Curcumin Exert a Beneficial Role?

Authors:  Rosaria Varì; Beatrice Scazzocchio; Annalisa Silenzi; Claudio Giovannini; Roberta Masella
Journal:  Nutrients       Date:  2021-03-22       Impact factor: 5.717

Review 8.  Curcumin: A Review of Its Effects on Epilepsy.

Authors:  Fatemeh Forouzanfar; Muhammed Majeed; Tannaz Jamialahmadi; Amirhosein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Carbon-based Nanomaterials and Curcumin: A Review of Biosensing Applications.

Authors:  Mohammad Mohajeri; Behzad Behnam; Aida Tasbandi; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.